fate stock price target

13 brokerages have issued 12 month target prices for Fate Therapeutics stock. Last Close Price.

15 Min Forex Scalping With Parabolic Sar 200 Ema Macd And Stochastic Forex Forex Trading Forex Signals

Guggenheim Adjusts Price Target for Fate Therapeutics to 78 From 107 Maintains Buy Rati.

. Their forecasts range from 6000 to 14500. The stock has traded between 3663 and 3932 so far today. In terms of how Fate Therapeutics Inc fares relative to Pharmaceutical Products stocks note that its average analyst price target is greater than 94038 of that group.

Stock for the coming years. The huge jump came after the biotech announced positive interim data from an early-stage. View FATE revenue estimates and earnings estimates as well as in-depth analyst breakdowns.

Find the latest Fate Therapeutics Inc FATE stock price forecast 12-month price target predictions and analyst recommendations. Analyst Price Target on FATE. In-depth view of key statistics and finances for FATE THERAPEUTICS INC.

Morgan Stanley Adjusts Fate. 15 2021 at 829 am. The average price target is 000 with a high estimate of 000 and a low estimate of 000.

Our community identified positive and negative aspects for Fate Therapeutics Inc. 1 Wall Street analyst that have issued a 1 year FAT price target the average FAT price target is 2500 with the highest FAT stock price forecast at 2500 and the lowest FAT stock price forecast at 2500The Wall Street analyst predicted. View real-time FATE stock price and news along with industry-best analysis.

FATE on MSN Money. FATE has a higher upside potential average analyst target price relative to current price than 100215 of stocks in the mid market cap category. Shares of Fate Therapeutics FATE -169 were skyrocketing 473 higher as of 1143 am.

ET by Tonya Garcia Barrons. The average price target represents a 14390 change from the last price of 3904. Average price target from 20 ratings.

This suggests a possible upside of 2117 from the stocks current price. Fate Therapeutics Inc FATE stock is trading at 3866 as of 132 PM on Tuesday Jan 25 a loss of -086 or -218 from the previous closing price of 3952. 3371 Average target price.

Based on 10 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months. The stock has traded between 3832 and 3995 so far today. Currency In USD.

That Fat Brandss share price could reach 2500 by Nov 9 2022. FATE Evolution of the average Target Price on FATE THERAPEUTICS INC. Complete Fate Therapeutics Inc.

Volume today is below average. Fate Therapeutics Inc. 130 rows The average price target is 10413 with a high forecast of 14500 and a low.

Fate Therapeutics upgraded to outperform from neutral at Wedbush price target raised to 74 from 71 Dec. The 4 Wall Street analysts offering Exxon Mobil stock forecast in the last 6 months have average price target of 645 with a high forecast of 750 and a low forecast of 500. The average Exxon Mobil stock forecast represents a -1713 decrease from the last price of 778300018310547.

Fate Therapeutics Inc FATE stock is trading at 3859 as of 940 AM on Friday Feb 11 an increase of 047 or 125 from the previous closing price of 3811. Find the latest Fate Therapeutics Inc. The average twelve-month price target for Fate Therapeutics is 10329 with a high price target of 14500 and a low price target of 6000.

9858 Spread Average Target. The average price target is 9522 with a high forecast of 13500 and a low forecast of 5000. On average they expect Fate Therapeutics stock price to reach 10329 in the next twelve months.

Among 10 analysts who have 12-month price forecasts on ContextLogic stock the median price target is 1750 with a high estimate of. With a target price of 8500 there is potential for a 168393 increase which would mean more than doubling the current price of 3167 for Fate Therapeutics Inc. 9 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 10311 with the highest FATE stock price forecast at 13000 and the lowest FATE stock price forecast at 7400.

Stock information by Barrons. Based on analysts offering 12 month price targets for FATE in the last 3 months. According to the issued ratings of 13 analysts in the last year the consensus rating for Fate Therapeutics stock is Buy based on the current 2 hold ratings and 11 buy ratings for FATE.

67 rows Current Price Target Price. Recommendations Chart FATE THERAPEUTICS INC. Research and ratings by Barrons.

FATE stock quote history news and other vital information to help you with your stock trading and investing. Analyst Recommendations on FATE THERAPEUTICS INC.

Fate Stock Price And Chart Nasdaq Fate Tradingview